David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
CALL
Biogen
BIIB
$32.7B
| $10M | 0.02% |
38,500
-61,100
| -61% | -$16.1M |
|
|
LPT
852
DELISTED
Liberty Property Trust
LPT
| $10M | 0.02% |
298,857
+143,564
| +92% | +$4.31M |
|
853
ScottsMiracle-Gro
SMG
$3.59B
| $9.99M | 0.02% |
137,355
-119,373
| -46% | -$8.12M |
|
|
SNDK
854
PUT
DELISTED
SANDISK CORP
SNDK
| $9.99M | 0.02% |
131,300
-307,900
| -70% | -$22.2M |
|
|
GRA
855
DELISTED
W.R. Grace & Co.
GRA
| $9.98M | 0.02% |
140,255
+41,740
| +42% | +$3.19M |
|
856
CALL
3M
MMM
$92.9B
| $9.98M | 0.02% |
71,640
+59,680
| +499% | +$7.67M |
|
857
Ternium
TX
$10.8B
| $9.97M | 0.02% |
554,491
+1,360
| +0.2% | +$19K |
|
858
Imperial Oil
IMO
$64.5B
| $9.96M | 0.02% |
298,166
+185,403
| +164% | +$5.79M |
|
859
Mercado Libre
MELI
$101B
| $9.96M | 0.02% |
84,535
-51,169
| -38% | -$5.3M |
|
|
WCC
860
WESCO International
WCC
$16.6B
| $9.9M | 0.02% |
181,155
-1,390
| -0.8% | -$61.8K |
|
861
Mercury Systems
MRCY
$5.24B
| $9.84M | 0.02% |
484,886
+1,416
| +0.3% | +$24.8K |
|
862
Texas Instruments
TXN
$237B
| $9.84M | 0.02% |
171,334
-665,944
| -80% | -$35.4M |
|
863
CALL
Kraft Heinz
KHC
$30B
| $9.82M | 0.02% |
125,000
+65,000
| +108% | +$4.86M |
|
|
ODP
864
DELISTED
ODP
ODP
| $9.8M | 0.02% |
137,999
-22,035
| -14% | -$1.19M |
|
865
Expeditors International
EXPD
$24.5B
| $9.73M | 0.02% |
199,410
+34,439
| +21% | +$1.58M |
|
866
Upbound Group
UPBD
$1.12B
| $9.72M | 0.02% |
613,254
+157,928
| +35% | +$2.11M |
|
|
SNDK
867
CALL
DELISTED
SANDISK CORP
SNDK
| $9.71M | 0.02% |
127,700
-78,700
| -38% | -$5.68M |
|
868
AB InBev
BUD
$155B
| $9.69M | 0.02% |
+77,734
| New | +$9.22M |
|
869
Rogers Communications
RCI
$19.7B
| $9.69M | 0.02% |
241,933
-487,807
| -67% | -$17.7M |
|
870
Acco Brands
ACCO
$388M
| $9.69M | 0.02% |
1,078,574
+63,874
| +6% | +$447K |
|
871
J.M. Smucker
SJM
$13.3B
| $9.68M | 0.02% |
74,567
-195,579
| -72% | -$24.7M |
|
872
PUT
Seagate
STX
$186B
| $9.65M | 0.02% |
280,200
-25,500
| -8% | -$822K |
|
873
Arthur J. Gallagher & Co
AJG
$68.7B
| $9.64M | 0.02% |
216,737
+37,793
| +21% | +$1.51M |
|
|
NSR
874
DELISTED
Neustar Inc
NSR
| $9.63M | 0.02% |
391,282
+242,763
| +163% | +$5.81M |
|
875
Pultegroup
PHM
$24.8B
| $9.61M | 0.02% |
513,497
-47,651
| -8% | -$813K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.